[Cancer in arthritis patients after anti-tumour necrosis factor therapy].

PubWeight™: 0.77‹?›

🔗 View Article (PMID 19210932)

Published in Ugeskr Laeger on February 09, 2009

Authors

Lene Dreyer1, Lene Mellemkjaer, Merete Lund Hetland

Author Affiliations

1: TA Reumatologisk Klinik 4242, Rigshospitalet, DK-2100 København Ø. lene.dreyer@dadlnet.dk

Articles by these authors

(truncated to the top 100)

Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol (2007) 3.04

Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med (2003) 2.24

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst (2010) 1.91

Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol (2008) 1.90

Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst (2006) 1.90

No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study. Ann Rheum Dis (2010) 1.89

Psychiatric hospitalizations among survivors of cancer in childhood or adolescence. N Engl J Med (2003) 1.89

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol (2010) 1.85

Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum (2008) 1.76

Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis. Arthritis Rheum (2009) 1.71

Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis. Arthritis Rheum (2011) 1.71

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries. Ann Rheum Dis (2011) 1.68

Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women. Int J Epidemiol (2004) 1.66

EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Ann Rheum Dis (2010) 1.63

Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important? J Rheumatol (2010) 1.62

Familial aggregation of Hodgkin lymphoma and related tumors. Cancer (2004) 1.60

Risk for cancer in parents of patients with schizophrenia. Am J Psychiatry (2004) 1.54

Fever of unknown origin and cancer: a population-based study. Lancet Oncol (2005) 1.52

Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer (2007) 1.46

Gain in quality-adjusted life-years in patients with rheumatoid arthritis during 1 year of biological therapy: a prospective study in clinical practice. J Rheumatol (2013) 1.46

Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry. Ann Rheum Dis (2010) 1.46

Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiol Biomarkers Prev (2005) 1.45

Detection, scoring and volume assessment of bone erosions by ultrasonography in rheumatoid arthritis: comparison with CT. Ann Rheum Dis (2012) 1.44

Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Hum Mutat (2010) 1.40

Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood (2006) 1.39

[Danish data document therapeutic effect differences of tumor necrosis factor inhibitors in patient with rheumatoid arthritis]. Ugeskr Laeger (2010) 1.39

Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry. Ann Rheum Dis (2012) 1.34

Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev (2005) 1.32

Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry. Ann Rheum Dis (2011) 1.28

Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state. J Rheumatol (2011) 1.27

Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Ann Rheum Dis (2010) 1.25

Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. J Rheumatol (2010) 1.24

Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study. Hepatogastroenterology (2003) 1.24

Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study. Cancer (2004) 1.21

Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study. Int J Cancer (2002) 1.18

Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor? Ann Rheum Dis (2007) 1.18

Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls. J Rheumatol (2009) 1.18

Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study. J Natl Cancer Inst (2007) 1.18

Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries. Blood (2006) 1.16

Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity. J Rheumatol (2013) 1.15

Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study. J Natl Cancer Inst (2004) 1.15

Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry. Arthritis Rheum (2011) 1.14

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration. Ann Rheum Dis (2011) 1.14

Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor α inhibitor therapy: results from the Danish Nationwide DANBIO Registry. Arthritis Rheum (2013) 1.12

Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study. J Clin Gastroenterol (2003) 1.10

Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial. Ann Rheum Dis (2013) 1.09

Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflamm Bowel Dis (2011) 1.09

Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med (2003) 1.08

Risk of second malignant neoplasms among lymphoma patients with a family history of cancer. Int J Cancer (2007) 1.07

Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia. Haematologica (2006) 1.07

Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases. J Rheumatol (2009) 1.07

Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.06

Risks of cancer among a cohort of 23,935 men and women with osteoporosis. Int J Cancer (2008) 1.00

Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993. Schizophr Res (2004) 1.00

Risk for breast cancer among women with endometriosis. Int J Cancer (2007) 1.00

Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol (2009) 1.00

What factors influence the health status of patients with rheumatoid arthritis measured by the SF-12v2 Health Survey and the Health Assessment Questionnaire? J Rheumatol (2009) 0.98

Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent? Ann Rheum Dis (2012) 0.98

Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study. Hum Mutat (2011) 0.98

Depression and cancer risk: a register-based study of patients hospitalized with affective disorders, Denmark, 1969-1993. Am J Epidemiol (2002) 0.97

Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population-based study in Denmark, 1994-2003. Eur J Cancer (2008) 0.96

No evidence for anticipation in lymphoproliferative tumors in population-based samples. Cancer Epidemiol Biomarkers Prev (2005) 0.95

A population-based cohort study of mortality among users of ibuprofen in Denmark. Am J Ther (2004) 0.94

What do patients in rheumatologic care know about the risks of NSAIDs? J Clin Rheumatol (2008) 0.93

Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study. Breast Cancer Res (2011) 0.92

Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors. Clin Rheumatol (2010) 0.92

Depigmentation--a rare side effect to intra-articular glucocorticoid treatment. Clin Rheumatol (2004) 0.90

Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report. Eur J Cancer (2013) 0.90

Relationships of uterine and ovarian tumors to pre-existing chronic conditions. Gynecol Oncol (2007) 0.89

Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry. Ann Rheum Dis (2012) 0.89

Seasonal variation in month of birth and diagnosis in children and adolescents with Hodgkin disease and non-Hodgkin lymphoma. J Pediatr Hematol Oncol (2003) 0.89

A population-based cohort study of mortality among adults prescribed paracetamol in Denmark. J Clin Epidemiol (2003) 0.88

Increased cancer risk in patients referred to hospital with suspected fibromyalgia. J Rheumatol (2007) 0.88

CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity'. Arthritis Res Ther (2014) 0.87

A registry-based study of gender, fetal growth, and risk of Wilms tumor. Pediatr Hematol Oncol (2004) 0.86

Survival patterns among lymphoma patients with a family history of lymphoma. J Clin Oncol (2008) 0.86

Age-specific incidence of breast cancer in breast cancer survivors and their first-degree relatives. Epidemiology (2009) 0.86

Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry. Ann Rheum Dis (2012) 0.86

The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program. Clin Exp Rheumatol (2014) 0.86

New remission criteria for RA: 'modern times' in rheumatology--not a silent film, rather a 3D movie. Ann Rheum Dis (2011) 0.84

Circulating surfactant protein -D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritis. Arthritis Res Ther (2010) 0.84

Sex differences in response to anti-tumor necrosis factor therapy in early and established rheumatoid arthritis -- results from the DANBIO registry. J Rheumatol (2011) 0.83

Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides. J Rheumatol (2010) 0.82

Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer Causes Control (2010) 0.82

NO excess risk of breast cancer among female users of systemic glucocorticoids. Cancer Epidemiol Biomarkers Prev (2005) 0.82

Re: Familial clustering of Hodgkin lymphoma and multiple sclerosis. J Natl Cancer Inst (2005) 0.82

Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis. J Rheumatol (2009) 0.81

Schizophrenia and the risk for breast cancer. Schizophr Res (2003) 0.80

Patterns of magnetic resonance imaging bone erosion in rheumatoid arthritis--which bones are most frequently involved and show the most change? J Rheumatol (2011) 0.79

Quality-adjusted life expectancies in patients with rheumatoid arthritis--comparison of index scores from EQ-5D, 15D, and SF-6D. Value Health (2012) 0.79

High risk of ischemic heart disease in patients with lupus nephritis. J Rheumatol (2011) 0.79

Use of systemic corticosteroids and risk of esophageal cancer. Epidemiology (2002) 0.78

Cancer preceding Wegener's granulomatosis: a case-control study. Rheumatology (Oxford) (2009) 0.78

[Health-related quality of life of patients with rheumatoid arthritis. Which factors are of significance?]. Ugeskr Laeger (2008) 0.77

Benign breast disease among first-degree relatives of young breast cancer patients. Am J Epidemiol (2008) 0.77

No erosive progression revealed by MRI in rheumatoid arthritis patients treated with etanercept, even in patients with persistent MRI and clinical signs of joint inflammation. Clin Rheumatol (2007) 0.77

Insulin-like growth factor I receptor density on CD4+T-lymphocytes from active early steroid- and DMARD-naïve rheumatoid arthritis patients is up-regulated and not influenced by 1 year of clinically effective treatment. Rheumatol Int (2011) 0.77

Keitel Functional Test for patients with rheumatoid arthritis: translation, reliability, validity, and responsiveness. Phys Ther (2008) 0.77

Mortality and causes of death in patients with "lupoid hepatitis." A long-term follow-up study in Denmark. Dan Med Bull (2002) 0.76

Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy. Biomark Insights (2009) 0.76